| 14-Oct-2021 | S | Johnson Pharmacare Ltd has informed BSE that the Board of Directors of the Company at its meeting held on October 14, 2021, inter alia, has recommended the proposal of sub-division of Company's 1 (one) equity shares of face value of Rs. 10/- each into 10 (ten) equity shares of face value of Rs 1/- each subject to approval by shareholders.
Further to our letter dated 22nd November, 2021 informing your esteemed Exchange about a proposal being submitted to the shareholders through Postal Ballot Notice dated 14th October, 2021 seeking their approval for the split of the 5, 00,00,000 equity shares of Rs.10/- each into 50,00,00,000 equity shares of Rs.1/each, we wish to inform you that the shareholders have approved the proposal and the company has fixed 6th January,2022 as the Record Date for the said split of the shares.
Thanking You.
(As Per BSE Announcement Dated on 30.11.2021)
Trading Members of the Exchange are hereby informed that JOHNSON PHARMACARE LTD., has fixed the Record Date for the purpose of sub division of equity shares of the company :
DEMATERIALISED SECURITIES - ROLLING SETTLEMENT SEGMENT
COMPANY NAME & CODE
JOHNSON PHARMACARE LTD.
(532154)
RECORD DATE
06.01.2022
PURPOSE
Sub Division of existing equity shares from every One equity share of Rs. 10/- each into Ten equity shares of Rs. 1/- each.
SUB-DIVIDED PAID-UP VALUE
Rs.1/-
SUB-DIVIDED PAID-UP VALUE W.E.F.
05/01/2022 DR- 192/2021-2022
Note:-
i. ISIN No. INE560F01014 of Rs.10/- paid up will not be valid for transactions done on the Exchange on or after 05/01/2022.
ii. The new ISIN Number for Rs.1/- paid up will be informed to the market by a separate notice.
(As Per BSE Notice Dated on 14.12.2021)
In Continuation of Notice No. 20211214-57 dated December 14, 2021, Trading Members of the Exchange are hereby informed that the New ISIN number for the equity shares of the company will be as under: -
Company Name & Scrip Code
JOHNSON PHARMACARE LTD.
(532154)
New ISIN No.
INE560F01022
Remarks
Sub-division of equity shares from Rs.10/- to Rs.1/-
The new ISIN number given above, for Equity Shares of Rs.1/- each of the company shall be effective for trades done on and from the Ex-Date i.e. 05-01-2022 (DR-192/2021-2022)
(As Per BSE Notice Dated 31.12.2021) | 06-Jan-2022 | |
| 24-Mar-2022 | B | 1:10 Bonus Issue of Equity Shares
Trading Members of the Exchange are hereby informed that, JOHNSON PHARMACARE LIMITED has fixed the record date for the purpose of Bonus Issue. The transactions in the equity shares of the company would be on an ex-bonus basis with effect from the under mentioned date.
DEMATERIALISED SECURITIES - ROLLING SETTLEMENT SEGMENT
COMPANY NAME & CODE
JOHNSON PHARMACARE LIMITED (532154)
RECORD DATE
08.04.2022
PURPOSE
Issue of 1 (One) Bonus equity shares of Re.1/- each for every 10 (Ten) existing equity share of Re.1/- each held.
Ex-Bonus basis from Date & Sett. No.
07/04/2022 DR-007/2022-2023
(As Per BSE Notice Dated on 04.04.2022) | 08-Apr-2022 | 1:10 |
| 15-Oct-2024 | BC | Johnson Pharmacare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/11/2024 inter alia to consider and approve PFA
Pursuant to Second proviso to Reg | 13-Nov-2024 | |
| 17-Sep-2024 | BC | AGM 28/09/2024
PFA
(As per BSE Announcement Dated on 28/09/2024) | 28-Sep-2024 | |
| 17-Sep-2024 | BC | Annual General Meeting | 21-Sep-2024 | |
| 25-Jul-2024 | BC | Johnson Pharmacare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 01/08/2024 inter alia to consider and approve 1.) To approve and take on record the Un | 01-Aug-2024 | |
| 16-May-2024 | BC | Johnson Pharmacare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 25/05/2024 inter alia to consider and approve Pursuant to Regulation 29 of the SEBI (L | 25-May-2024 | |
No Dividends has been declared by Johnson_Pharma
Record Date08-Apr-2022
Ex-Bonus Date07-Apr-2022
Ratio1:10
Record Date06-Jan-2022
Split Date05-Jan-2022
Face Value (Before/After)10/1
RightsNo Rights has been declared by Johnson_Pharma
Book Closure
| 13-Nov-2024 | - | Johnson Pharmacare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/11/2024 inter alia to consider and approve PFA
Pursuant to Second proviso to Reg |
| 28-Sep-2024 | - | AGM 28/09/2024
PFA
(As per BSE Announcement Dated on 28/09/2024) |
| 21-Sep-2024 | 01 Jan'1900 | Annual General Meeting |
| 01-Aug-2024 | - | Johnson Pharmacare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 01/08/2024 inter alia to consider and approve 1.) To approve and take on record the Un |
| 25-May-2024 | - | Johnson Pharmacare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 25/05/2024 inter alia to consider and approve Pursuant to Regulation 29 of the SEBI (L |